In a health alert, the FDA recalls nearly 1.8 million cartons of eye care products. The recall hits over‐the‐counter eye drops. The FDA found manufacturing issues in a recent audit. The audit flagged problems with quality and sterility. Reports about safety issues rise as allergy cases grow.
What You Need to Know About the Recall
AvKARE, the maker of these products, called for this recall after the audit. The FDA noted a missing guarantee of sterility. The company did not give full details but warned that risks to users remain a chance.
Affected Products
This recall covers eye care items sold from May 26, 2023, to April 21, 2025. The items include:
- Artificial Tears Ophthalmic Solution (NDC# 50268-043-15)
- Carboxymethylcellulose Sodium Ophthalmic Gel 1% (NDC# 50268-066-15)
- Carboxymethylcellulose Sodium Ophthalmic Solution (NDC# 50268-068-15)
- Lubricant Eye Drops Solution (NDC# 50268-126-15)
- Polyvinyl Alcohol Ophthalmic Solution (NDC# 50268-678-15)
Consumers must stop using these products and check their supplies.
Steps for Affected Consumers
If you have any of these products, follow these steps:
- Cease use immediately.
- Compare the lot numbers and dates with the FDA notice.
- Contact AvKARE for a full refund on returns, including shipping.
The company expresses regret for this trouble and asks consumers to act soon.
Allergy Season and Eye Health
This recall comes when many face strong allergy symptoms. Weather changes bring longer pollen periods. People experience more eye discomfort in this season. Dry eyes, scratchiness, redness, burning, or blurred vision affect daily life. Using safe products helps keep eyes calm.
Conclusion
With more allergy cases and this recall, staying informed keeps your eyes safe. Check your supplies against the recall list and find other options if needed. Use products that work well for you, and talk with your doctor for advice.